Literature DB >> 11290771

CD99 signals caspase-independent T cell death.

R D Pettersen1, G Bernard, M K Olafsen, M Pourtein, S O Lie.   

Abstract

Death signaling by Fas and TNF receptors plays a major role in the control of activated mature T cells. However, the nature of the death receptors, which may be used by the immune system to control T cells that have not acquired susceptibility to Fas ligand or TNF, is not established. In this study, we demonstrate that engagement of distinct epitopes on CD99 rapidly induces T cell death by a novel caspase-independent pathway. A new mAb to these CD99 epitopes, Ad20, induces programmed cell death of transformed T cells as determined by morphological changes, phosphatidylserine exposure on the cell surface, and uptake of propidium iodide. In general, ligation of CD99 induced kinetically faster and more profound death responses as compared with the impact of anti-Fas and TNF-related apoptosis-inducing ligand (TRAIL). Ad20-induced programmed cell death was observed with seven of eight T cell lines examined, and notably, only two of these were distinctly responsive to anti-Fas and TRAIL. CD99-mediated death signaling proceeded independently of functional CD3, CD4, CD45, and p56(lck), revealed distinctions from CD47-mediated T cell death responses, and was not influenced by interference with CD47 signaling. In contrast to the effect on transformed T cell lines, Ad20-induced death responses were not observed with normal peripheral T cells. Thus, our data suggest that CD99 is linked to a novel death pathway that may have biologic relevance in control of early T cells.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11290771     DOI: 10.4049/jimmunol.166.8.4931

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  26 in total

Review 1.  A novel, alternative pathway of apoptosis triggered through class II major histocompatibility complex molecules.

Authors:  Zoltan A Nagy; Nuala A Mooney
Journal:  J Mol Med (Berl)       Date:  2003-10-09       Impact factor: 4.599

2.  Correlation of CD95 and soluble CD95 expression with acute rejection status of liver transplantation.

Authors:  Yu-Liang Wang; Yan-Yan Zhang; Guang Li; Zhi-Qin Tang; Yan-Li Zhou; Zhi-Jun Zhu; Zhi Yao
Journal:  World J Gastroenterol       Date:  2005-03-21       Impact factor: 5.742

3.  In vivo tumouricidal effects of LAD-1 monoclonal antibody on murine RL-male-1 lymphoma mediated by enhanced phagocytosis.

Authors:  M Ito; S Omoto; Y Kato; T Hayashi; N Mori; Y R Fujii
Journal:  Clin Exp Immunol       Date:  2005-07       Impact factor: 4.330

4.  Nuclear factor-κB2 represses Sp1-mediated transcription at the CD99 promoter.

Authors:  Eun Kyung Lee; Ji Hye Chae; Myung-Soo Kang
Journal:  Mol Cells       Date:  2011-10-19       Impact factor: 5.034

5.  CD99 acts as an oncosuppressor in osteosarcoma.

Authors:  Maria Cristina Manara; Ghislaine Bernard; Pier-Luigi Lollini; Patrizia Nanni; Monia Zuntini; Lorena Landuzzi; Stefania Benini; Giovanna Lattanzi; Marika Sciandra; Massimo Serra; Mario Paolo Colombo; Alain Bernard; Piero Picci; Katia Scotlandi
Journal:  Mol Biol Cell       Date:  2006-01-18       Impact factor: 4.138

Review 6.  CD99 in malignant hematopoiesis.

Authors:  Atham Ali; Vijaya Pooja Vaikari; Houda Alachkar
Journal:  Exp Hematol       Date:  2021-12-14       Impact factor: 3.249

7.  The Human Pseudoautosomal Region (PAR): Origin, Function and Future.

Authors:  A Helena Mangs; Brian J Morris
Journal:  Curr Genomics       Date:  2007-04       Impact factor: 2.236

8.  CD99 is essential for leukocyte diapedesis in vivo.

Authors:  Eric M Dufour; Alana Deroche; Youngmee Bae; William A Muller
Journal:  Cell Commun Adhes       Date:  2008-11

9.  High-valency Anti-CD99 Antibodies Toward the Treatment of T Cell Acute Lymphoblastic Leukemia.

Authors:  Larizbeth A Romero; Takamitsu Hattori; Mohamed A E Ali; Gayatri Ketavarapu; Akiko Koide; Christopher Y Park; Shohei Koide
Journal:  J Mol Biol       Date:  2021-12-24       Impact factor: 5.469

10.  Activation of natural killer cells and dendritic cells upon recognition of a novel CD99-like ligand by paired immunoglobulin-like type 2 receptor.

Authors:  Ikuo Shiratori; Kouetsu Ogasawara; Takashi Saito; Lewis L Lanier; Hisashi Arase
Journal:  J Exp Med       Date:  2004-02-16       Impact factor: 14.307

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.